on one allele of the PTCH gene; moreover, BCCs and other tumors in these patients exhibit a second somatic mutation and/or loss of heterozygosity (LOH), thereby fulfilling the criteria of the two-hit model of molecular carcinogenesis and identifying PTCH as a tumor suppressor gene (Hahn et ...